Merck Overcomes Avoro Challenge to Acceleron Acquisition

Paul, Weiss helped Merck navigate an activist hedge fund challenge and successfully consummate its $11.5 billion acquisition of Acceleron, a biopharmaceutical company focused on rare disease treatments, the largest biotech deal completed in 2021.

The Paul, Weiss team included corporate partners Scott Barshay and Laura Turano.